Phreesia Bundle
What is the history of Phreesia?
Phreesia, founded in January 2005 by Chaim Indig and Evan Roberts, aimed to modernize patient intake. Headquartered in Wilmington, Delaware, the company sought to empower patients and streamline provider workflows.
The company has grown significantly, now handling around 170 million patient visits annually, which is about one in every seven patient visits in the U.S. as of 2024. This extensive reach highlights its role in patient activation solutions.
Phreesia's journey includes becoming a publicly traded company on the NYSE (PHR) starting July 18, 2019. This marks a key milestone in its expansion and influence within healthcare technology. The company's offerings, such as those analyzed in the Phreesia BCG Matrix, demonstrate its strategic approach to market positioning.
What is the Phreesia Founding Story?
The Phreesia company origin story begins in January 2005, founded by Chaim Indig and Evan Roberts. Their vision was to revolutionize the patient intake process in healthcare, moving away from outdated paper methods.
Phreesia's Founding Story
Phreesia was established in January 2005 by Chaim Indig, who continues to lead as CEO, and Evan Roberts, currently the President of Provider Solutions. Michael Weintraub has served as the chairman of the board since the company's inception. Their combined expertise in technology and market penetration, honed at companies like Spotfire, provided a strong foundation for their innovative approach to healthcare technology.
- Co-founders Chaim Indig and Evan Roberts brought prior experience from the analytics software sector.
- The company identified inefficiencies in traditional paper-based patient intake.
- The initial solution involved a wireless touchscreen device, the 'PhreesiaPad,' for patient self-registration.
- The goal was to improve provider efficiency and the patient experience.
- The company's mission and vision history is rooted in streamlining healthcare interactions.
The founders recognized a significant pain point in healthcare: the cumbersome and inefficient patient check-in process that relied on paper clipboards. They envisioned a digital solution to streamline this, enhancing both operational efficiency for healthcare providers and the overall patient experience. This led to the development of the 'PhreesiaPad,' a wireless touchscreen device designed to replace traditional clipboards, allowing patients to securely and compliantly self-register, provide necessary information, and make payments. The technology was engineered for seamless integration with existing physician workflows and electronic medical records (EMRs).
Phreesia's early development and growth were supported by strategic funding. The company secured its first round of financing on December 14, 2006. By September 2007, Phreesia had successfully raised $13.25 million, with a significant $10.25 million Series B round led by Polaris Venture Partners, joined by HLM Venture Partners, Long River Ventures, and Village Ventures. This early backing from prominent venture capital firms validated the potential of their patient check-in solution. Further bolstering its financial position, Phreesia closed a Series D equity financing round in September 2010, bringing the total capital raised in that round to $20 million, with VantagePoint Venture Partners joining as a new investor alongside existing stakeholders. This funding was crucial for the Phreesia evolution and expansion.
Phreesia SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
What Drove the Early Growth of Phreesia?
In its early stages, the company focused on developing its patient intake platform, starting with the innovative 'PhreesiaPad'. This initial product aimed to streamline patient registration and payment processing for healthcare practices.
Foundational Product Development
The company's early efforts centered on creating a robust patient intake platform. The 'PhreesiaPad' was a key development, designed to automate administrative tasks and improve data capture for healthcare providers.
Securing Capital and Public Offering
Significant capital raises, including a $34 million Series F in December 2017, underscored investor confidence. A major milestone was the company's Initial Public Offering (IPO) on July 18, 2019, on the NYSE under the ticker PHR, providing substantial funds for expansion.
Expanding Service Offerings and Market Reach
The company broadened its solutions to encompass appointment scheduling and digital registration, covering more of the patient journey. This expansion also involved strategic acquisitions, such as QueueDr and Insignia Health in 2021, and Access eForms in August 2023, enhancing its capabilities.
Financial Growth and Profitability
The company has demonstrated consistent revenue growth, with total revenue reaching $419.8 million in fiscal year 2025, an 18% increase from fiscal 2024. This growth, coupled with strategic initiatives, led to a return to profitability, with Adjusted EBITDA turning positive in Q1 Fiscal 2025 and positive free cash flow of $8.3 million reported for fiscal 2025. Understanding the Competitors Landscape of Phreesia provides context for this growth.
Phreesia PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
What are the key Milestones in Phreesia history?
The Phreesia company background is one of consistent growth and innovation in the healthcare technology sector. From its inception, the company has focused on improving the patient experience and streamlining administrative processes within healthcare practices. This journey has been marked by significant achievements, including strategic partnerships and a successful public offering, underscoring its impact on patient intake and engagement. The Brief History of Phreesia details this evolution.
| Year | Milestone |
|---|---|
| 2005 | Phreesia was founded with a vision to revolutionize patient intake. |
| 2007 | Introduction of the PhreesiaPad, digitizing the patient check-in process. |
| July 18, 2019 | Phreesia completed its initial public offering (IPO). |
| 2024 | Recognized as one of The Software Report's 'Top 100 Software Companies', ranking 11th. |
| 2025 | Named to G2's Best Healthcare Software Products list. |
| 2025 | Included in Black Book Research's list of Top-Rated Vendors for Patient Access and Front-End Management Solutions. |
| March 2025 | Won a Bronze 2025 PM360 Pharma Choice Award for a campaign addressing linguistic barriers in healthcare. |
Phreesia's innovation is centered on enhancing the patient journey and operational efficiency for healthcare providers. The company pioneered the PhreesiaPad, a wireless touchscreen device that transformed the traditional paper-based patient check-in into a digital, interactive experience. This innovation facilitates real-time data capture, payment processing, and personalized patient education, significantly improving front-end workflows.
PhreesiaPad Digitization
The introduction of the PhreesiaPad replaced paper forms with a wireless touchscreen, digitizing the patient check-in process.
AI Integration
Ongoing investment in product development includes AI integration to enhance client solutions and operational efficiency.
National Footprint Expansion
Major partnerships have been instrumental in establishing a broad national footprint and collaborating with leading healthcare organizations.
Public Offering
The company's IPO in July 2019 provided significant capital for continued growth and market expansion.
Industry Recognition
Consistent recognition from industry bodies like G2, Black Book Research, and The Software Report highlights its leadership in patient access solutions.
Award-Winning Campaigns
Collaborative campaigns, such as the one addressing linguistic barriers, have earned industry accolades, demonstrating a commitment to inclusive healthcare communication.
Despite its successes, Phreesia has navigated significant challenges, particularly impacting its financial outlook. The company experienced a negative revenue impact in fiscal 2025 due to the accelerated wind-down of a clearinghouse client relationship, a situation exacerbated by a cyber attack on Change Healthcare. This led to a downward revision of their fiscal 2025 revenue guidance.
Clearinghouse Client Wind-Down
A notable challenge in fiscal 2025 involved the accelerated wind-down of a clearinghouse client relationship, which negatively impacted revenue.
Impact of Cyber Attack
The cyber attack on Change Healthcare influenced the decision to accelerate the clearinghouse client relationship wind-down, contributing to revenue challenges.
Revenue Outlook Adjustment
The company adjusted its fiscal 2025 revenue outlook downwards due to the aforementioned client relationship changes.
Adjusted EBITDA Outlook Increase
Despite revenue challenges, the company demonstrated resilience by updating its Adjusted EBITDA outlook upwards for fiscal 2025, signaling a focus on profitability.
Strategic Resilience
Phreesia's ability to navigate these challenges through strategic adjustments and a focus on operational discipline highlights its adaptability in the dynamic healthcare technology market.
Focus on Profitable Growth
The upward revision of the Adjusted EBITDA outlook reflects a strategic shift towards prioritizing profitable growth and continued margin improvement.
Phreesia Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What is the Timeline of Key Events for Phreesia?
The Phreesia company history is a story of consistent innovation in patient intake and engagement. Founded with a clear vision, the company has steadily grown through strategic funding, key acquisitions, and a commitment to improving the healthcare experience for both patients and providers. This evolution showcases a dedication to its core mission.
| Year | Key Event |
|---|---|
| 2005 | Phreesia was founded by Chaim Indig and Evan Roberts in Wilmington, Delaware, with the goal of digitizing patient intake processes. |
| 2006 | The company secured its initial funding round, marking the beginning of its financial growth. |
| 2007 | A significant Series B funding round of $10.25 million was closed, bringing the total financing to $13.25 million. |
| 2010 | Phreesia completed a $20 million Series D funding round, broadening its investor base and fueling further expansion. |
| 2019 | Phreesia completed its Initial Public Offering (IPO) on July 18, beginning to trade on the NYSE under the ticker PHR, a major milestone in its Phreesia company origin story. |
| 2021 | The company expanded its product offerings through the acquisitions of QueueDr (now Appointment Accelerator) and Insignia Health. |
| 2023 | Phreesia acquired Access eForms, enhancing its capabilities in electronic forms management. |
| 2025 | Phreesia was recognized on G2's 2025 Best Healthcare Software Products list and named a Top-Rated Vendor for Patient Access and Front-End Management Solutions by Black Book Research. |
Financial Performance and Growth
For fiscal year 2025, Phreesia reported total revenue of $419.8 million, an 18% increase year-over-year. The company also achieved positive free cash flow of $8.3 million, demonstrating strong operational efficiency and a healthy Revenue Streams & Business Model of Phreesia.
Future Outlook and Strategy
Looking ahead, Phreesia anticipates continued revenue growth, projecting $472 million to $482 million for fiscal year 2026. The company is strategically investing in AI integration to enhance its product suite and deliver more scalable solutions.
Client Expansion and Market Position
Phreesia expects its Average Healthcare Services Clients (AHSCs) to reach approximately 4,200 for fiscal 2025 and around 4,500 in fiscal 2026. This expansion reflects its growing impact on patient intake and front-end management in healthcare.
Analyst Confidence and Stock Performance
Analysts maintain an optimistic outlook on Phreesia, with a potential upside of 18.74% in the stock price. This confidence is rooted in the company's strategic focus and its consistent ability to drive efficiency and improve healthcare outcomes.
Phreesia Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Competitive Landscape of Phreesia Company?
- What is Growth Strategy and Future Prospects of Phreesia Company?
- How Does Phreesia Company Work?
- What is Sales and Marketing Strategy of Phreesia Company?
- What are Mission Vision & Core Values of Phreesia Company?
- Who Owns Phreesia Company?
- What is Customer Demographics and Target Market of Phreesia Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.